Abstract:Demyelination and axonal degeneration are fundamental pathological characteristics of multiple sclerosis (MS), an inflammatory disease of the central nervous system (CNS). Although the molecular mechanisms driving these processes are not fully understood, hepatocyte growth factor (HGF) has emerged as a potential regulator of neuroinflammation and tissue protection in MS. Elevated HGF levels have been reported in MS patients receiving immunomodulatory therapy, indicating its relevance in disease modulation. This study investigated HGF's neuroprotective effects using transgenic mice that overexpressed HGF. The experimental autoimmune encephalomyelitis (EAE) model, which mimics MS pathology, was employed to assess demyelination and axonal damage in the CNS. HGF transgenic mice showed delayed EAE progression, with reduced CNS inflammation, decreased demyelination, and limited axonal degeneration. Scanning electron microscopy confirmed the preservation of myelin and axonal integrity in these mice. In addition, we explored HGF's effects using a cuprizone-induced demyelination model, which operates independently of the immune system. HGF transgenic mice exhibited significant protection against demyelination in this model as well. We also investigated the expression of key HGF receptors, particularly c-Met and KAI-1. While c-Met, which is associated with increased inflammation, was upregulated in EAE, its expression was significantly reduced in HGF transgenic mice, correlating with decreased neuroinflammation. Conversely, KAI-1, which has been linked to axonal protection and stability, showed enhanced expression in HGF transgenic mice, suggesting a protective mechanism against axonal degeneration. These findings underscore HGF's potential in preserving CNS structure and function, suggesting it may be a promising therapeutic target for MS, offering new hope for mitigating disease progression and enhancing neuroprotection.

FGF/FGFR system in the central nervous system demyelinating disease: Recent progress and implications for multiple sclerosis

Immune System Dysregulation in the Progression of Multiple Sclerosis: Molecular Insights and Therapeutic Implications

Recent Progress in Multiple Sclerosis Treatment Using Immune Cells as Targets

Effect of Fingolimod on Neural Stem Cells: A Novel Mechanism and Broadened Application for Neural Repair.

Integrative Systems and Functional Analyses Reveal a Role of Dopaminergic Signaling in Myelin Pathogenesis.

Progressive multiple sclerosis: latest therapeutic developments and future directions

Neuron and Microglia/macrophage-Derived FGF10 Activate Neuronal FGFR2/PI3K/Akt Signaling and Inhibit Microglia/macrophages TLR4/NF-κB-dependent Neuroinflammation to Improve Functional Recovery after Spinal Cord Injury.

Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis

Fibroblast Growth Factor Signalling in the Diseased Nervous System

Central nervous system regeneration: the roles of glial cells in the potential molecular mechanism underlying remyelination

Unveiling the fate and potential neuroprotective role of neural stem/progenitor cells in multiple sclerosis

New targets and therapeutics for neuroprotection, remyelination and repair in multiple sclerosis

Implications for Multiple Sclerosis Pathology

Modulation of the Microglial Nogo-A/NgR Signaling Pathway as a Therapeutic Target for Multiple Sclerosis

The remyelination effect of DNA framework nucleic acids on demyelinating diseases

The role of fibronectin in multiple sclerosis and the effect of drug delivery across the blood-brain barrier

Cell‐based experimental strategies for myelin repair in multiple sclerosis

Immunopathogenesis of multiple sclerosis: molecular and cellular mechanisms and new immunotherapeutic approaches

Combination Therapy With Fingolimod and Neural Stem Cells Promotes Functional Myelination in vivo Through a Non-immunomodulatory Mechanism

Wnt Signaling in Remyelination in Multiple Sclerosis: Friend or Foe?

Cell-based remyelinating therapy in inflammatory demyelinating injury of the CNS